Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for Zeltiq Aesthetics Inc�
31.22
+0.39 (1.26%)
Apr 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 29.86 - 31.31
52 week 13.30 - 35.90
Open 30.71
Vol / Avg. 448,671.00/583,383.00
Mkt cap 1.19B
P/E 1,599.39
Div/yield     -
EPS 0.02
Shares 38.12M
Beta -0.08
Inst. own 98%
Apr 27, 2015
Q1 2015 ZELTIQ Aesthetics Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 12, 2015
ZELTIQ Aesthetics Inc at Barclays Healthcare Conference
Mar 9, 2015
ZELTIQ Aesthetics Inc at ROTH Conference
Mar 3, 2015
Q4 2014 ZELTIQ Aesthetics Inc Earnings Call
Mar 3, 2015
Q4 2014 ZELTIQ Aesthetics Inc Earnings Release
Feb 18, 2015
ZELTIQ Aesthetics Inc at BTIG Snowbird Conference
Feb 11, 2015
ZELTIQ Aesthetics Inc at Leerink Global Healthcare Conference
Jan 14, 2015
ZELTIQ Aesthetics Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 2.59% 0.88%
Operating margin 3.16% 1.22%
EBITD margin - 2.26%
Return on average assets 5.30% 1.60%
Return on average equity 7.60% 2.30%
Employees 408 -
CDP Score - -

Address

4698 Willow Rd Ste 100
PLEASANTON, CA 94588-2806
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons, and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. The Company has an installed base of 2,175 CoolSculpting systems installed across approximately 1,900 practices across the world. Approximately 972,612 CoolSculpting cycles has been shipped to its customers and distributors.

Officers and directors

Mark J. Foley President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Patrick Williams Chief Financial Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Keith Sullivan Senior Vice President of Worldwide Sales
Age: 56
Bio & Compensation  - Reuters
Len DeBenedictis Chief Technology Officer
Age: 73
Bio & Compensation  - Reuters
Carl H Lamm Vice President of Operations
Age: 52
Bio & Compensation  - Reuters
Mary M. Fisher Director
Age: 52
Bio & Compensation  - Reuters
D. Keith Grossman Director
Bio & Compensation  - Reuters
Jean M. George Independent Director
Age: 56
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Independent Director
Age: 59
Bio & Compensation  - Reuters